Ibrutinib therapy downregulates AID enzyme and proliferative fractions in chronic lymphocytic leukemia

Pablo Elías Morande, Mariela Sivina, Angimar Uriepero, Noé Seija, Catalina Berca, Pablo Fresia, Ana Inés Landoni, Javier M. Di Noia, Jan A. Burger, Pablo Oppezzo*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

11 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Ibrutinib therapy downregulates AID enzyme and proliferative fractions in chronic lymphocytic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds